The biotech process development center at Sputnik Technopolis, operated by R-Pharm Group – a resident of the Technopolis Moscow special economic zone – is working on 11 original molecules to develop new therapies for cancer and autoimmune diseases, announced Deputy Mayor Maxim Liksutov.
